The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?
Open accessAbstract
What is the purpose of publications?…[The]purpose of data is to support, directly or indirectly, the marketing of our product.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“It has been repeatedly and firmly established that pharmaceutical company funding strongly biases published results in favor of the company’s products [17–19].”
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Delen, D., Sharda, R., Turban, E., Aronson, J. E., & King, D. R. (2007) · Cited by 925
(2018) · The Hastings Center Report · doi:10.1002/(issn)1552-146x · Cited by 852
Uneasy alliance—clinical investigators and the pharmaceutical industry
Bodenheimer, T. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422024 · Cited by 765 · cited 1×
“The industry provides twice as much funding for clinical trials and related research as do not-for-profit agencies [27].”
Withholding Research Results in Academic Life Science: Evidence From a National Survey of Faculty
Blumenthal, D. (1997) · JAMA · doi:10.1001/jama.1997.03540390054035 · Cited by 576
Prevalence of Articles With Honorary Authors and Ghost Authors in Peer-Reviewed Medical Journals
Flanagin, A. (1998) · JAMA · doi:10.1001/jama.280.3.222 · Cited by 553
Values and Organizational Structure
Hinings, C. R., Thibault, L., Slack, T., & Kikulis, L. M. (1996) · Human Relations · doi:10.1177/001872679604900702 · Cited by 444
When Authorship Fails: A Proposal to Make Contributors Accountable
Rennie, D. (1997) · JAMA · doi:10.1001/jama.1997.03550070071041 · Cited by 396
Editorial peer review for improving the quality of reports of biomedical studies
Jefferson, T., Rudin, M., Brodney Folse, S., & Davidoff, F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000016.pub3 · Cited by 312
Pharmaceutical company funding and its consequences: A qualitative systematic review
Sismondo, S. (2008) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.08.001 · Cited by 304
Self-citationGhost Authorship in Industry-Initiated Randomised Trials
Gøtzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G., & Chan, A.-W. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040019 · Cited by 289
The Contract Research Organization and the Commercialization of Scientific Research
Mirowski, P., & Van Horn, R. (2005) · Social Studies of Science · doi:10.1177/0306312705052103 · Cited by 260
Prevalence of Honorary and Ghost Authorship in Cochrane Reviews
Mowatt, G. (2002) · JAMA · doi:10.1001/jama.287.21.2769 · Cited by 227
Interface between authorship, industry and science in the domain of therapeutics
Healy, D., & Cattell, D. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.1.22 · Cited by 218
Peer Review for Journals as it Stands Today—Part 1
CAMPANARIO, J. M. (1998) · Science Communication · doi:10.1177/1075547098019003002 · Cited by 195
Multiple Authorship: The Contribution of Senior Authors
Drenth, J. P. H. (1998) · JAMA · doi:10.1001/jama.280.3.219 · Cited by 178
Shaping the Intimate: Influences on the Experience of Everyday Nerves
Healy, D. (2004) · Social Studies of Science · doi:10.1177/0306312704042620 · Cited by 160
Schafer, A. (2004) · Journal of Medical Ethics · doi:10.1136/jme.2003.005702 · Cited by 156
Ghost Marketing: Pharmaceutical Companies and Ghostwritten Journal Articles
Moffatt, B., & Elliott, C. (2007) · Perspectives in biology and medicine · doi:10.1353/pbm.2007.0009 · Cited by 133
Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry
Mello, M. M., Clarridge, B. R., & Studdert, D. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044115 · Cited by 132
Peer Review for Journals as it Stands Today—Part 2
CAMPANARIO, J. M. (1998) · Science Communication · doi:10.1177/1075547098019004002 · Cited by 132
A New Trade Framework for Global Healthcare R&D
Hubbard, T., & Love, J. P. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020052 · Cited by 109
Haunted Manuscripts: Ghost Authorship in the Medical Literature
Ngai, S., Gold, J., Gill, S. S., & Rochon, P. A. (2005) · Accountability in Research · doi:10.1080/08989620590957175 · Cited by 82
Pharma Goes to the Laundry: Public Relations and the Business of Medical Education
Elliott, C. (2004) · The Hastings Center Report · doi:10.2307/3527586 · Cited by 78
Psychology in the Prescription Era: Building a Firewall Between Marketing and Science.
Antonuccio, D. O., Danton, W. G., & McClanahan, T. M. (2003) · American Psychologist · doi:10.1037/0003-066x.58.12.1028 · Cited by 65
Fugh‐Berman, A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.05857.x · Cited by 59
Implications of Pharmaceutical Industry Funding on Clinical Research
Lexchin, J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e224 · Cited by 56
Larkin, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75272-7 · Cited by 31
Evidence in Vioxx suits shows intervention by Merck officials.
(2005) · Cited by 28
Research works printed but not linked: 26
- Moffatt, 2007, Perspect Biol Med, 50, 18
- Antonuccio, 2003, Am Psychol, 58, 1028
- Blumsohn, 2006, AAAS Professional Ethics Report, 29, 1
- Fugh-Berman, 2005, J Gen Intern Med, 20, 546
- Healy, 2004, Soc Stud Sci, 34, 219
- Larkin, 1999, Lancet, 354, 136
- Mathews, 2005 December 13, The Wall Street Journal, A1
- Lagnado, 2002, Lancet, 359, 902
- Drenth, 1998, JAMA, 280, 219
- Lexchin, 2003, BMJ, 326, 1167
- Bekelman, 2003, JAMA, 289, 454
- Flanagin, 1998, JAMA, 280, 222
- Mowatt, 2002, JAMA, 287, 2769
- Gøtzsche, 2007, PLoS Med, 4, e19
- Healy, 2003, Br J Psychiatry, 183, 22
- Golden, 2002, J Contin Educ Health Prof, 22, 55
- Bodenheimer, 2000, New Engl J Med, 342, 1539
- Mirowski, 2005, Soc Stud Sci, 35, 503
- Blumenthal, 1997, JAMA, 277, 1224
- Lexchin, 2005, Ann Pharmacother, 39, 194
- Mello, 2005, New Engl J Med, 352, 2202
- Schafer, 2004, J Med Ethics, 30, 8
- Hubbard, 2004, PLoS Biol, 2, e52
- Campanario, 1998, Sci Commun, 19, 181
- Campanario, 1998, Sci Commun, 19, 277
- Rennie, 1997, JAMA, 278, 579
Cited by
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Kirmayer, L. J. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.03.018 · Cited by 341
Ghosts in the Machine: Publication Planning in the Medical Sciences
Sismondo, S. (2009) · Social Studies of Science · doi:10.1177/0306312708101047 · Cited by 297
Self-citationThe promise and perils of industry‐funded science
Holman, B., & Elliott, K. C. (2018) · Philosophy Compass · doi:10.1111/phc3.12544 · Cited by 88
How Metrics-Based Academic Evaluation Could Systematically Induce Academic Misconduct: A Case Study
Han, J., & Li, Z. (2018) · East Asian Science, Technology and Society: An International Journal · doi:10.1215/18752160-4275144 · Cited by 13
Metadata
- Authors
- Sismondo, S.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-09-25
- Volume
- 4
- Issue
- 9
- Pages
- e286
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2110124949
- Cited by
- 259
- References
- 30
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.